The estimated Net Worth of Christopher J Hocevar is at least $844 Mille dollars as of 2 March 2018. Mr. Hocevar owns over 2,759 units of American Renal Associates stock worth over $314,511 and over the last 8 years he sold ARA stock worth over $529,287. In addition, he makes $0 as Independent Director at American Renal Associates.
Sign up
Mr. Hocevar ARA stock SEC Form 4 insiders trading
Christopher has made over 2 trades of the American Renal Associates stock since 2017, according to the Form 4 filled with the SEC. Most recently he sold 2,759 units of ARA stock worth $529,287 on 2 March 2018.
The largest trade he's ever made was exercising 11,164 units of American Renal Associates stock on 27 November 2017 worth over $1,144,980. On average, Christopher trades about 1,547 units every 11 days since 2017. As of 2 March 2018 he still owns at least 8,751 units of American Renal Associates stock.
You can see the complete history of Mr. Hocevar stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Christopher Hocevar biography
Christopher J. Hocevar serves as Independent Director of the Company. Mr. Hocevar currently serves as an independent consultant to Centerbridge. He previously had a 16-year career at Cigna Corporation, where he most recently served as President, U.S. Commercial Healthcare Segments and Specialty Businesses until 2018. He joined Cigna in 2002 and held numerous roles of progressive responsibility leading customer segments, specialty lines of business and operational units. Prior to Cigna, Mr. Hocevar worked in Deloitte & Touche’s global insurance consulting practice. He holds a Bachelor of Business Administration from the University of Toledo and a Master of Business Administration from Case Western Reserve University.
How old is Christopher Hocevar?
Christopher Hocevar is 46, he's been the Independent Director of American Renal Associates since 2020. There are 9 older and 2 younger executives at American Renal Associates. The oldest executive at American Renal Associates Holdings Inc. is Robert Fish, 69, who is the Independent Director.
Insiders trading at American Renal Associates
Over the last 9 years, insiders at American Renal Associates have traded over $0 worth of American Renal Associates stock and bought 2,870 units worth $63,140 . The most active insiders traders include Thomas W Erickson, Joseph A Carlucci e Syed T Kamal. On average, American Renal Associates executives and independent directors trade stock every 215 days with the average trade being worth of $4,293,860. The most recent stock trade was executed by Joseph A Carlucci on 9 June 2020, trading 416,720 units of ARA stock currently worth $533,402.
What does American Renal Associates's logo look like?
Complete history of Mr. Hocevar stock trades at American Renal Associates e Cigna
American Renal Associates executives and stock owners
American Renal Associates executives and other stock owners filed with the SEC include:
-
Don Williamson,
Chief Operating Officer, Executive Vice President -
Thomas Erickson,
Independent Director -
Joseph Carlucci,
Chairman of the Board, Chief Executive Officer, Co-Founder -
Syed Kamal,
President, Co-Founder, Director -
John Jureller,
Independent Director -
Michael Boxer,
Independent Director -
Robert Fish,
Independent Director -
Christopher Hocevar,
Independent Director -
Jeremy Gelber,
Independent Director -
Darren Lehrich,
SVP Strategy & Investor Relations -
Jared Hendricks,
Independent Director -
Susanne Clark,
Independent Director -
Mark Herbers,
Interim Chief Financial Officer, Interim Chief Accounting Officer -
Jason Boucher,
Former VP & CFO -
Patrick T Ryan,
Director -
John J Mcdonough,
EVP, COO AND TREASURER -
Michael Ray Costa,
VP and General Counsel -
Jonathan L Wilcox,
VP & Chief Financial Officer -
Victoria Labriola,
VP and General Counsel -
Capital Partners L Pcenterb...,